NewGenIvf Group Limited (NASDAQ:NIVF) Shares Shorted: Short Interest Down 94.9% in October

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a large decline in short interest during the month of October. As of October 30th, there was short interest totaling 125,342 shares, a decline of 94.9% from the October 15th total of 2,470,389 shares. Approximately 16.5% of the shares of the company are sold short. Based on an average daily volume of 934,259 shares, the days-to-cover ratio is presently 0.1 days.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Wall Street Zen lowered NewGenIvf Group to a “strong sell” rating in a report on Saturday, October 24th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, November 2nd. One investment analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock has a consensus rating of “Sell”.

NewGenIvf Group Trading Down 3.5%

NIVF traded down $0.01 on Wednesday, hitting $0.27. 58,286 shares of the company’s stock were exchanged, compared to its average volume of 413,118. NewGenIvf Group has a fifty-two week low of $0.27 and a fifty-two week high of $8,266.75. The firm has a 50-day moving average price of $11.91 and a 200-day moving average price of $349.50.

NewGenIvf Group (NASDAQ:NIVF) last issued its earnings results on Wednesday, October 7th. The company reported ($111.54) earnings per share (EPS) for the quarter, missing the consensus estimate of $581.76 by ($693.30). The business had revenue of $0.96 million during the quarter, compared to the consensus estimate of $20.10 million. Research analysts forecast that NewGenIvf Group will post 1365.44 earnings per share for the current fiscal year.

About NewGenIvf Group

NewGenIvf Group Limited (NASDAQ:NIVF) is a fertility-services company focused on assisted reproductive technology and related medical care. Through its NewGen IVF operations, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), fertility assessments and fertility-preservation procedures. Its service offering also includes egg and sperm freezing, embryo-related services, genetic testing and donor-program support, subject to applicable medical and regulatory requirements.